Singaporean Scientists Uncover Potential Treatment for Acute Kidney InjuryResearchers in Singapore have unveiled a breakthrough in the realm of acute …
Latest in clinical trials
-
-
MedicineMental HealthOregon Health & Science UniversitySciTech NewsStress
Recent Study Casts Doubt on the Effectiveness of Xanax
by Manuel Costaby Manuel CostaNew study questions Xanax’s efficacy, suggesting inflated claims by over 40%. Potential impact on clinical practice.
-
CancerDrugsFree University Of BrusselsMetastisisSciTech News
Pioneering Advances: Innovative Approach to Counter Metastasis and Chemotherapy Resistance in Cancer
by Manuel Costaby Manuel CostaResearchers find that inhibiting Netrin-1 molecule can counter cancer metastasis and chemotherapy resistance. Early human trials are encouraging, as the …
-
AntibodiesHIVInstitut PasteurSciTech NewsVirology
The Magic Bullet for HIV-1? Discovering the Powerhouse Antibody
by Amir Husseinby Amir HusseinA Potential Key to HIV-1 Management: Unveiling the Potent Antibody EPTC112Antibody fragments of EPTC112 bNAb, identified by the research team …
-
Champalimaud Centre For The UnknownDepressionMedicineMental HealthPsychedelicsSciTech News
Esketamine Nasal Spray: A Revolutionary Approach for Treating Resistant Depression
by Amir Husseinby Amir HusseinThis comprehensive article delves into the efficacy of esketamine nasal spray as a breakthrough treatment for treatment-resistant depression (TRD). It …
-
BMJDementiaDrugsFDAMedicinePublic HealthSciTech News
FDA’s Shocking Approval: Rexulti Fast-Tracked Despite Deadly Risks
Exposé: FDA’s controversial fast-tracking of Rexulti, an antipsychotic drug for dementia patients, sparks safety and ethics concerns.
-
Alzheimer'sAmerican Academy Of NeurologyDementiaMedicineNeuroscienceSciTech NewsUniversities
Limited Access to New Alzheimer’s Treatments: Study Reveals Narrow Eligibility Criteria
This comprehensive study reveals that only a small percentage of older adults with early Alzheimer’s symptoms are eligible for new …
-
CancerCold Spring Harbor LaboratoryEMBL-EBIImmunotherapyMITPopularSciTech NewsTumor
Why Does Immunotherapy Not Always Work? New Research Sheds Light
by Amir Husseinby Amir HusseinWhy Immunotherapy Sometimes Fails: Recent Research Provides InsightsImmunotherapy has been a groundbreaking approach in the battle against cancer, offering hope …
-
CholesterolDrugsHeart AttackMonash UniversitySciTech News
Revolutionary Drug Unveiled for Treating Previously Untreatable Form of Cholesterol
Revolutionary oral drug Muvalaplin decreases hereditary cholesterol Lipoprotein(a) by 65%, offering the first-ever treatment for this cardiovascular risk. The drug, …
-
DrugsMonash UniversityPublic HealthSciTech News
Life-Saver or Risky Gamble? New Study Sheds Light on Controversial Drug for Trauma Care
by Manuel Costaby Manuel CostaIn-Depth Study on Tranexamic Acid’s Role in Trauma Care: Survival Impact and Long-Term Quality of Life Effects Explored.
- 1
- 2